Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Liver Transplantation After ex Vivo Liver Perfusion - The EVOLVE Study

NCT05951231 is registered in ClinicalTrials.gov with Oslo University Hospital as lead sponsor.

NCT NCT05951231
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05951231 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Liver Transplantation After ex Vivo Liver Perfusion - The EVOLVE Study
Lead sponsor
Oslo University Hospital
Phase
Not applicable
Overall status
Not yet recruiting
Start date
February 29, 2024
Completion date
February 28, 2029
Enrollment
22 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

liver cancer, liver metastases, liver transplant; complications, transplant, transplant dysfunction, transplant; complication, rejection, transplant; failure, liver